These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 21788458

  • 1. In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
    Ripoll A, Baquero F, Novais A, Rodríguez-Domínguez MJ, Turrientes MC, Cantón R, Galán JC.
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4530-6. PubMed ID: 21788458
    [Abstract] [Full Text] [Related]

  • 2. Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.
    Novais A, Cantón R, Coque TM, Moya A, Baquero F, Galán JC.
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2377-82. PubMed ID: 18443114
    [Abstract] [Full Text] [Related]

  • 3. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
    Galán JC, Morosini MI, Baquero MR, Reig M, Baquero F.
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
    [Abstract] [Full Text] [Related]

  • 4. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH, Bae IK, Kwon SB, Lee JH, Song JS, Jung HI, Sung KH, Jang SJ, Lee SH.
    J Appl Microbiol; 2005 Aug; 98(4):921-7. PubMed ID: 15752339
    [Abstract] [Full Text] [Related]

  • 5. Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
    Docobo-Pérez F, López-Cerero L, López-Rojas R, Egea P, Domínguez-Herrera J, Rodríguez-Baño J, Pascual A, Pachón J.
    Antimicrob Agents Chemother; 2013 May; 57(5):2109-13. PubMed ID: 23439636
    [Abstract] [Full Text] [Related]

  • 6. Convergent in vivo and in vitro selection of ceftazidime resistance mutations at position 167 of CTX-M-3 beta-lactamase in hypermutable Escherichia coli strains.
    Stepanova MN, Pimkin M, Nikulin AA, Kozyreva VK, Agapova ED, Edelstein MV.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1297-301. PubMed ID: 18212109
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the risk of acquiring in vitro resistance to doripenem and tazobactam/piperacillin by CTX-M-15-producing Escherichia coli.
    Horiyama T, Kanazawa S, Hara T, Izawa M, Sato T, Yamaguchi T, Tsuji M, Maki H.
    J Infect Chemother; 2015 May; 21(5):381-4. PubMed ID: 25662788
    [Abstract] [Full Text] [Related]

  • 8. Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
    Rossi B, Soubirou JF, Chau F, Massias L, Dion S, Lepeule R, Fantin B, Lefort A.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):424-30. PubMed ID: 26525800
    [Abstract] [Full Text] [Related]

  • 9. Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam.
    Shahi SK, Singh VK, Kumar A.
    PLoS One; 2013 Jan; 8(7):e68234. PubMed ID: 23861873
    [Abstract] [Full Text] [Related]

  • 10. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L, Picón E, Morillo C, Hernández JR, Docobo F, Pachón J, Rodríguez-Baño J, Pascual A.
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [Abstract] [Full Text] [Related]

  • 11. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
    Tian GB, Huang YM, Fang ZL, Qing Y, Zhang XF, Huang X.
    J Antimicrob Chemother; 2014 Aug; 69(8):2081-5. PubMed ID: 24777903
    [Abstract] [Full Text] [Related]

  • 12. Emergence and dominance of CTX-M-15 extended spectrum beta-lactamase among Escherichia coli isolates from children.
    Réjiba S, Mercuri PS, Power P, Kechrid A.
    Microb Drug Resist; 2011 Jun; 17(2):135-40. PubMed ID: 21288137
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E, Kühn A, Mack D, Laufs R.
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [Abstract] [Full Text] [Related]

  • 18. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.
    Shaheen BW, Nayak R, Foley SL, Kweon O, Deck J, Park M, Rafii F, Boothe DM.
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5666-75. PubMed ID: 21947397
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.